Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2005
08/31/2005CN1660174A Mixture of eliminating sputum and relieving asthma and preparation method
08/31/2005CN1660171A Method for producing injection of houttuynia
08/31/2005CN1660170A Soft capsule of houttuynia and preparation method
08/31/2005CN1660160A Combination of Chinese traditional medicine in use for treating atypical pneumonia etc communicable diseases
08/31/2005CN1660133A Low alcohol type concentrated soloution for nourishing yin to clear away the lung-heat, preparation method and application
08/31/2005CN1660114A Compound antitussive
08/31/2005CN1660113A Effervescence piece of Sulfogaiacol, pentoxyverine and promet hazine and preparation technique
08/31/2005CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660107A Solid preparation taken through oral cavity of compound MEthoxyphEnaminE and preparation method
08/31/2005CN1660087A Soft capsule of fibrauretine and preparation method
08/31/2005CN1660078A Oral disintegration tablet of bergenin and compound bergenin and preparation method
08/31/2005CN1660077A Xiyanping drop pills of possessing function of clearing away heat and toxic materia and preparation method
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216609C Scutellaria root extract nose preparation
08/31/2005CN1216600C Levo-salbutamol hydrochloride aerosol and its prepn.
08/30/2005US6936718 Reacting with acid mixed with solvent; salt formation
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof.
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936603 Treating autoimmune diseases mediated by cathepsin S
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005CA2336968C Quinoline derivatives
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077399A1 Preventive and therapeutic agent for chronic obstructive pulmonary disease
08/25/2005WO2005077393A1 Herbal formulation comprising extracts of adhatoda, hedychium and curcuma as cough syrup
08/25/2005WO2005077364A1 Transdermal solifenacin preparation and method of improving transdermal permeability thereof
08/25/2005WO2005077362A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
08/25/2005WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR
08/25/2005WO2003098385A3 System and method for transparent early detection, warning, and intervention during a medical procedure
08/25/2005US20050187380 Method for treating Th2-mediated disease
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints
08/25/2005US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5)
08/25/2005US20050187226 A1 adenosine receptor antagonists
08/25/2005US20050187164 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186575 Corona-virus-like particles comprising functionally deleted genomes
08/25/2005US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/25/2005US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same
08/25/2005US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide
08/25/2005US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit
08/25/2005DE29924789U1 New, stable crystalline polymorph (form III) of the diuretic torasemide, by controlled acidification of alkaline solutions, has more rapid dissolution than form I
08/25/2005CA2556086A1 Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2555149A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
08/25/2005CA2554465A1 Piperidine derivatives useful as ccr3 antagonists
08/25/2005CA2552871A1 Novel, sustained-action beta-2-agonists and their use as medicaments
08/24/2005EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use
08/24/2005EP1565475A1 Diazinopyrimidines
08/24/2005EP1565431A1 Cannabinoid receptor ligands
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
08/24/2005EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
08/24/2005EP1372624B1 Tramadol-based medicament
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1335917B1 Condensed pyridoindole derivatives
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways
08/24/2005CN1659180A Novel recombinant anticoagulant proteins
08/24/2005CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1658896A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
08/24/2005CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
08/24/2005CN1658893A G-type peptides to ameliorate atherosclerosis
08/24/2005CN1658886A Hormone replacement therapy
08/24/2005CN1658885A Hormone replacement therapy
08/24/2005CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
08/24/2005CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
08/24/2005CN1658872A Antiallergic
08/24/2005CN1658866A Tri-substituted heteroaryls and methods of making and using the same
08/24/2005CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
08/24/2005CN1658863A Severe sepsis preventive therapeutic agent
08/24/2005CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients
08/24/2005CN1658839A Dry powder compositions
08/24/2005CN1658837A Dry powder inhalant composition
08/24/2005CN1658834A Method of treating mucus hypersecretion
08/24/2005CN1657102A SARS-Cov gene vaccine based on epi-position and its contruction
08/24/2005CN1657083A Oral Chinese medicinal preparation for treating acute pharyngolaryngitis
08/24/2005CN1657071A Asarum brain injection and its preparation method
08/24/2005CN1657064A Nasal suppository for treating thinitis
08/24/2005CN1657056A Preparation and use of vasodilation liquid
1 ... 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 ... 878